Alloplast as an alternative for dorsal augmentation.

Area of Science:

• Plastic Surgery
• Biomaterials Science

Background:

• Dorsal augmentation is increasingly common in rhinoplasty due to a growing ethnic population in the US.
• Graft material procurement for nasal augmentation presents challenges, exacerbated by expanding applications for limited cartilage.
• The use of alloplasts for dorsal augmentation remains a topic of debate.

Purpose of the Study:

• To evaluate the efficacy and safety of expanded polytetrafluoroethylene (ePTFE) for nasal dorsal augmentation.
• To assess patient satisfaction and complication rates associated with ePTFE use in rhinoplasty.

Main Methods:

• Review of over 15 years of clinical experience with ePTFE in nasal dorsal augmentation.
• Analysis of patient selection criteria and surgical techniques employed.
• Assessment of complication rates and patient satisfaction outcomes.

Main Results:

• Expanded polytetrafluoroethylene (ePTFE) has demonstrated over 15 years of successful application in nasal dorsal augmentation.
• Proper patient selection and surgical technique are crucial for optimal outcomes.
• The use of ePTFE in the nasal dorsum is associated with relatively low complication rates.

Conclusions:

• Expanded polytetrafluoroethylene (ePTFE) is a safe and effective alternative for nasal dorsal augmentation.
• High patient satisfaction can be achieved with ePTFE when used appropriately in rhinoplasty.
• ePTFE addresses the challenges of limited autologous graft availability in reconstructive nasal surgery.